Information
145 Gwanggyo-ro, Yeongtong-gu, Suwon, Gyeonggi-do, South Korea
+82 31-624-5162
-
-
Overview
- Summary
- A specialized company in diagnostic systems based on ultra-precision mass spectrometry. Development, production, and sales of TOF mass spectrometers for medical disease diagnosis, microbial testing, and industrial applications in display, secondary battery, semiconductor, and environmental sectors. Provision of innovative solutions in both medical and industrial fields through a cloud-based diagnostic platform. A research and development-oriented listed company utilizing mass spectrometry technology for bio and polymer materials.A specialized company in diagnostic systems based on ultra-precision mass spectrometry. Development, production, and sales of TOF mass spectrometers for medical disease diagnosis, microbial testing, and industrial applications in display, secondary battery, semiconductor, and environmental sectors. Provision of innovative solutions in both medical and industrial fields through a cloud-based diagnostic platform. A research and development-oriented listed company utilizing mass spectrometry technology for bio and polymer materials.
- Key Products/Technologies
- MALDI-TOF MS (Matrix-Assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry) based medical diagnostic systems. Possession of IDSys (Integrated Diagnostics System) product lines including IDSys LT, IDSys Elite, IDSys RT (Premier*), and IDSys Cyclone models. IDSys RT (Premier*) is a high-sensitivity/high-resolution mass spectrometer used for early diagnosis of various cancers such as ovarian, breast, and pancreatic cancer, and for research and development in early diagnosis of neurodegenerative diseases like Parkinson's and Alzheimer's. MicroIDSys, a MALDI-TOF system for microbial identification, offers one-touch operation for results within 5 minutes.MALDI-TOF MS (Matrix-Assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry) based medical diagnostic systems. Possession of IDSys (Integrated Diagnostics System) product lines including IDSys LT, IDSys Elite, IDSys RT (Premier*), and IDSys Cyclone models. IDSys RT (Premier*) is a high-sensitivity/high-resolution mass spectrometer used for early diagnosis of various cancers such as ovarian, breast, and pancreatic cancer, and for research and development in early diagnosis of neurodegenerative diseases like Parkinson's and Alzheimer's. MicroIDSys, a MALDI-TOF system for microbial identification, offers one-touch operation for results within 5 minutes.
- Industrial analysis systems include LDI-TOF (Laser Desorption Ionization Time of Flight), an OLED analysis and inspection mass spectrometer capable of direct pixel-unit analysis. The LDI-TOF features an ultra-fine focus laser optical system capable of analyzing spot sizes of 5㎛ or less and operating software based on web technology (node.js). TGA-TOF (Thermogravimetric Analysis-Time of Flight Mass Spectrometer) combines thermogravimetric analysis with electron ionization time-of-flight mass spectrometry for quantitative/qualitative analysis of gases generated during thermal analysis. GM-TOF (Gas Monitoring TOF) is utilized as a gas monitoring system.Industrial analysis systems include LDI-TOF (Laser Desorption Ionization Time of Flight), an OLED analysis and inspection mass spectrometer capable of direct pixel-unit analysis. The LDI-TOF features an ultra-fine focus laser optical system capable of analyzing spot sizes of 5㎛ or less and operating software based on web technology (node.js). TGA-TOF (Thermogravimetric Analysis-Time of Flight Mass Spectrometer) combines thermogravimetric analysis with electron ionization time-of-flight mass spectrometry for quantitative/qualitative analysis of gases generated during thermal analysis. GM-TOF (Gas Monitoring TOF) is utilized as a gas monitoring system.
- The cloud-based MALDI-TOF mass spectrometry platform provides diagnostic services leveraging extensive cancer, microbial, and viral data stored in a central data center. Reproducibility Enhanced MALDI-TOF and Rapid ID-AST platforms are under development for simultaneous pathogen identification and antimicrobial susceptibility testing. A high-precision early cancer detection platform integrates AI-driven data analysis, establishing a new diagnostic paradigm.The cloud-based MALDI-TOF mass spectrometry platform provides diagnostic services leveraging extensive cancer, microbial, and viral data stored in a central data center. Reproducibility Enhanced MALDI-TOF and Rapid ID-AST platforms are under development for simultaneous pathogen identification and antimicrobial susceptibility testing. A high-precision early cancer detection platform integrates AI-driven data analysis, establishing a new diagnostic paradigm.
- Disposable sample plates (MALDI Plate) are essential consumables for MALDI-TOF mass spectrometry systems, developed and manufactured in-house.Disposable sample plates (MALDI Plate) are essential consumables for MALDI-TOF mass spectrometry systems, developed and manufactured in-house.
- Core Advantages
- Proprietary mass spectrometry technology capabilities in developing MALDI-TOF and LDI-TOF based medical diagnostic and industrial analysis systems. The LDI-TOF, in particular, offers differentiated performance with its ultra-fine focus laser optical system and web-based operating software.Proprietary mass spectrometry technology capabilities in developing MALDI-TOF and LDI-TOF based medical diagnostic and industrial analysis systems. The LDI-TOF, in particular, offers differentiated performance with its ultra-fine focus laser optical system and web-based operating software.
- Successful expansion into diverse industrial sectors beyond medical diagnostics, including the development and supply of analysis equipment for display, secondary battery, semiconductor, and environmental industries. This contributes to market diversification and a stable revenue structure.Successful expansion into diverse industrial sectors beyond medical diagnostics, including the development and supply of analysis equipment for display, secondary battery, semiconductor, and environmental industries. This contributes to market diversification and a stable revenue structure.
- Rapid and accurate diagnostic systems, exemplified by the IDSys's one-touch, 5-minute result capability and ongoing R&D in early cancer and neurodegenerative disease diagnosis. This represents a significant strength in enhancing diagnostic efficiency and accuracy for patients.Rapid and accurate diagnostic systems, exemplified by the IDSys's one-touch, 5-minute result capability and ongoing R&D in early cancer and neurodegenerative disease diagnosis. This represents a significant strength in enhancing diagnostic efficiency and accuracy for patients.
- Cloud-based platform and AI utilization capabilities, including leveraging vast cancer, microbial, and viral data from central data centers and AI-driven data analysis for improved diagnostic accuracy. This is a key competitive advantage in leading the next-generation diagnostic paradigm.Cloud-based platform and AI utilization capabilities, including leveraging vast cancer, microbial, and viral data from central data centers and AI-driven data analysis for improved diagnostic accuracy. This is a key competitive advantage in leading the next-generation diagnostic paradigm.
- Proactive efforts for global market entry and achievement of international certifications such as CE-IVD, ISO 13485, ISO 9001, and ISO 14001. Chinese CFDA certification and ongoing US FDA approval processes, along with accelerated expansion into Middle Eastern markets like Saudi Arabia, are crucial for global competitiveness.Proactive efforts for global market entry and achievement of international certifications such as CE-IVD, ISO 13485, ISO 9001, and ISO 14001. Chinese CFDA certification and ongoing US FDA approval processes, along with accelerated expansion into Middle Eastern markets like Saudi Arabia, are crucial for global competitiveness.
- Recognition for technological excellence through prestigious awards, including the 2016 Korea Technology Award Prime Minister's Prize, IR52 Jang Young-sil Award, NET/NEP certifications, and Patent Office Director's Awards. These accolades affirm the company's innovation and superior technological capabilities.Recognition for technological excellence through prestigious awards, including the 2016 Korea Technology Award Prime Minister's Prize, IR52 Jang Young-sil Award, NET/NEP certifications, and Patent Office Director's Awards. These accolades affirm the company's innovation and superior technological capabilities.
- Target Industrie
- Medical/Healthcare: Disease diagnosis, microbial testing, early cancer diagnosis, neurodegenerative disease diagnosis, etc..Medical/Healthcare: Disease diagnosis, microbial testing, early cancer diagnosis, neurodegenerative disease diagnosis, etc..
- Display: OLED material composition analysis and quality control (QC).Display: OLED material composition analysis and quality control (QC).
- Secondary Batteries: Material analysis and impurity measurement.Secondary Batteries: Material analysis and impurity measurement.
- Semiconductor: High-speed residual gas analysis in manufacturing processes and process gas monitoring systems.Semiconductor: High-speed residual gas analysis in manufacturing processes and process gas monitoring systems.
- Environment: Gas monitoring systems.Environment: Gas monitoring systems.
- Bio: Analysis of biomaterials such as DNA, proteins, peptides, and glycans.Bio: Analysis of biomaterials such as DNA, proteins, peptides, and glycans.
- Material Industry: Mass spectrometry analysis of polymer materials and trace analysis of high molecular weight substances.Material Industry: Mass spectrometry analysis of polymer materials and trace analysis of high molecular weight substances.
- Major Markets
- South Korea, China, Saudi Arabia, Japan, TaiwanSouth Korea, China, Saudi Arabia, Japan, Taiwan
- Germany, Broader European MarketGermany, Broader European Market
- United StatesUnited States
- Certifications/Patents
- CE-IVD (DoC) certification.CE-IVD (DoC) certification.
- ISO 13485 CERTIFICATION, ISO 14001 certification, ISO 9001 certification.ISO 13485 CERTIFICATION, ISO 14001 certification, ISO 9001 certification.
- Acquisition of NET certification (magnetic particle composites) and NEP certification (REDS).Acquisition of NET certification (magnetic particle composites) and NEP certification (REDS).
- Medical device manufacturing license, venture company confirmation, corporate R&D center accreditation.Medical device manufacturing license, venture company confirmation, corporate R&D center accreditation.
- Family company certification from Korea Basic Science Institute, innovative product designation certification, small and medium-sized enterprise confirmation.Family company certification from Korea Basic Science Institute, innovative product designation certification, small and medium-sized enterprise confirmation.
- Acquisition of China FDA Certification (CFDA) and Taiwan FDA Certification.Acquisition of China FDA Certification (CFDA) and Taiwan FDA Certification.
- REDS patent acquisition and cancer diagnosis interpretation method patent application.REDS patent acquisition and cancer diagnosis interpretation method patent application.
- Korean and US patents related to MALDI-TOF mass spectrometry systems and essential disposable sample plates.Korean and US patents related to MALDI-TOF mass spectrometry systems and essential disposable sample plates.
- Patents related to high-resolution LDI-TOF mass spectrometry technology.Patents related to high-resolution LDI-TOF mass spectrometry technology.
- Recipient of the 2016 Korea Technology Award Prime Minister's Prize (Microbial Identification MALDI-TOF System).Recipient of the 2016 Korea Technology Award Prime Minister's Prize (Microbial Identification MALDI-TOF System).
- Recipient of the IR52 Jang Young-sil Award (high-resolution LDI-TOF mass spectrometry technology).Recipient of the IR52 Jang Young-sil Award (high-resolution LDI-TOF mass spectrometry technology).
- Recipient of the Research Industry Commissioner of the Korean Intellectual Property Office Award and the 2024 Korea Intellectual Property Exhibition Commissioner of the Korean Intellectual Property Office Award (LDI-TOF).Recipient of the Research Industry Commissioner of the Korean Intellectual Property Office Award and the 2024 Korea Intellectual Property Exhibition Commissioner of the Korean Intellectual Property Office Award (LDI-TOF).
Introduction
Location
145 Gwanggyo-ro, Yeongtong-gu, Suwon, Gyeonggi-do, South Korea
클릭하여 위치 살펴보기
